Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study. (Q41113513)
Jump to navigation
Jump to search
scientific article published on 19 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study. |
scientific article published on 19 November 2015 |
Statements
Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study (English)
A C M van Bommel
C A Drukker
M van der Heiden-van der Loo
S C Linn
E J Th Rutgers
S G Elias
19 November 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference